Posted Dec. 10, 2012 at 7:15 a.m.

Premium Lock GSK strikes $335M drug deal with Texas cancer center

Published: 2012-12-10 07:15:00
Updated: 2012-12-10 07:15:00

Print this blog post
Cancer research Cancer research Image 1 of 2 · Next Image…

GlaxoSmithKline signs a research and development deal with the MD Anderson Cancer Center in Texas that will focus on using the body's immune system to fight cancer. The deal could be worth $335 million plus royalties....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll